Table 4.
Hemodynamic and CFV Measurements Before and During ATP Infusion
| Control (n=30) | IBD (n=37) | P Value | |
|---|---|---|---|
| Heart rate, beats per min | |||
| Baseline | 62.8±9.7 | 68.8±10.6 | 0.001 |
| ATP infusion | 80.7±11.6 | 85.4±12.9 | 0.122 |
| Δ Heart rate | 17.8±6.5 | 16.7±10.5 | 0.590 |
| SBP, mm Hg | |||
| Baseline | 132.7±15.6 | 117.8±15.6 | <0.001 |
| ATP infusion | 111.1±13.7 | 103.8±13.1 | 0.029 |
| Δ SBP | −21.6±7.9 | −14.1±7.4 | <0.001 |
| DBP, mm Hg | |||
| Baseline | 86.4±9.4 | 74.2±13.0 | <0.001 |
| ATP infusion | 65.5±9.0 | 62.9±9.8 | 0.265 |
| Δ DBP | −20.9±7.4 | −11.4±9.3 | <0.001 |
| Mean DFV, cm/s | |||
| Baseline | 14.6±4.3 | 16.9±4.7 | 0.042 |
| ATP infusion | 54.0±10.0 | 47.2±11.2 | 0.012 |
| CFVR | 3.84±0.75 | 2.95±0.89 | <0.001 |
CFV indicates coronary flow velocity; CFVR, coronary flow velocity reserve; DFV, diastolic flow velocity; DBP, diastolic blood pressure; IBD, inflammatory bowel disease; and SBP, systolic blood pressure.